HomeInsights
INDUSTRY:
Pharma
TOPIC:
Regulatory & Legal, Products & Services, Business & People, Manufacturers & Providers, Distributors&Retailers
TITLE:
MoH: Pricing amendments passed into legislation
BRIEF:
In an Order just published, the Ministry of Health puts forward a series of changes to the currently applicable pricing regulatory framework, which are likely to have a significant impact on the operations of all the companies present on the local pharma market.
LEGAL IMPLICATIONS:
BUSINESS IMPLICATIONS:
